(Reuters) – A U.S. Centers for Disease Control and Prevention advisory panel is set to meet on Wednesday to discuss the use of a booster dose of Pfizer and BioNTech’s COVID-19 vaccine for children aged 12 to 15 years, according to the agency’s website https://www.cdc.gov/vaccines/acip/index.html.
(Reporting by Manojna Maddipatla in Bengaluru; Editing by Ramakrishnan M.)
Australia’s Grace Kim opens 4-stroke lead in LPGA Tour’s JM Eagle LA Championship
NFL to allow players to wear protective soft-shell helmet covers during games
No. 1 NFL draft pick Caleb Williams realizes all eyes are on him and he’s embracing the attention
Caitlin Clark revs up Pacers fans with pregame playoff appearance in IndyCar replica
Orioles send former No. 1 pick Jackson Holliday back to minors after he hit .059 in 10 MLB games
Midwest tornadoes cause severe damage in Omaha suburbs
Biden officials indefinitely postpone ban on menthol cigarettes amid election-year pushback
A ban in Kansas on gender-affirming care also would bar advocacy for kids’ social transitions
South Dakota governor, a potential Trump running mate, writes in new book about killing her dog
140,000 people did their taxes with the free IRS direct file pilot. But program’s future is unclear
Biden officials indefinitely postpone ban on menthol cigarettes amid election-year pushback
A ban in Kansas on gender-affirming care also would bar advocacy for kids’ social transitions
What to know about Bell’s palsy, the facial paralysis affecting Joel Embiid
South Korean police raid office of incoming head of doctors’ group over protracted strikes
